A Double-Blind, Randomized Phase II Study of Dicycloplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel as First-Line Therapy for Patients With Advanced Non-Small-Cell Lung Cancers
Archives of Medical Science - Poland
doi 10.5114/aoms.2014.44862
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2014
Authors
Publisher
Termedia Sp. z.o.o.